Collegium Pharm

COLL NASDAQ
10.83
-0.41
-3.65%
After Hours: 10.83 0 0.00% 17:04 07/16 EDT
Open
11.13
Prev Close
11.24
High
11.16
Low
10.79
Volume
293.37K
Avg Vol (3M)
325.93K
52 Week High
21.20
52 Week Low
10.55
% Turnover
0.88%
Market Cap
361.58M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Collegium Pharm COLL stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical company. The Company is engaged in developing and commercializing abuse-deterrent products that incorporate its DETERx platform technology for the treatment of chronic pain and other diseases. Its products include Xtampza ER and ONSOLIS. Its DETERx platform provides extended-release drug delivery, while safeguarding against common methods of abuse and tampering, including crushing, chewing, and heating and injecting. Xtampza ER is designed to provide adequate pain control while maintaining its extended-release drug release profile after being subjected to common methods of abuse and accidental misuse. ONSOLIS is a Transmucosal Immediate-Release Fentanyl (TIRF) film indicated for the management of breakthrough pain in cancer patients (BTPc), 18 years of age and older, who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain.
MORE >

Recently

Name
Price
%Change